Invitrogen™ LYPD1 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA526749

Catalog No. PIPA526749

Description

LYPD1 Polyclonal Antibody for Western Blot, IHC (P)

Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro increases receptor desensitization and decreases affinity for ACh of alpha-4:beta-2- containing nAChRs. May play a role in the intracellular trafficking of alpha-4:beta-2 and alpha-7-containing nAChRs and may inhibit their expression at the cell surface. May be involved in the control of anxiety.

Specifications

• Antigen: LYPD1
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: LYPD1
• Gene Alias: 2700050C12Rik; AI853408; C530008O16Rik; Ly-6/neurotoxin-like protein 2; LY6/PLAUR domain containing 1; ly6/PLAUR domain-containing protein 1; Lynx2; LYPD1; Lypdc1; MNCb-0671; PHTS; PSEC0181; Putative HeLa tumor suppressor; UNQ3079/PRO9917
• Host Species: Rabbit
• Purification Method: Antigen affinity chromatography, Protein A
• Regulatory Status: RUO
• Gene ID (Entrez): 116372, 72585
• Content And Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin), Western Blot
• Concentration: 0.5 mg/mL
• Formulation: PBS with 0.09% sodium azide; pH 7.4
• Gene Accession No.: Q8BLC3, Q8N2G4
• Gene Symbols: LYPD1
• Immunogen: KLH conjugated synthetic peptide between 93-122 amino acids from the C-terminal region of human LYPD1.
• Quantity: 400 μL
• Primary or Secondary: Primary
• Target Species: Human, Mouse
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov